Article
Molecular target therapeutics of EGF-TKI and downstream signaling pathways in non-small cell lung cancers.
Journal of the Chinese Medical Association : JCMA - 1 Apr 2022
Liu Chao-Yu, Lin Heng-Fu, Lai Wei-Yi, Lin Yi-Ying, Lin Tzu-Wei, Yang Yi-Ping, Tsai Fu-Ting, Wang Chia-Lin, Luo Yung-Hung, Chen Yuh-Min, Hsu Po-Kuei, Kai Loh Jit, Kiat Alan Ong Han, Chien Yueh, Chiou Shih-Hwa, Wang Chien-Ying
Abstract excerpt
Lung carcinoma (LC) is the third most common cancer diagnosis and accounted for the most cancer-related mortality worldwide in 2018. Based on the type of cells from which it originates, LC is commonly classified into non-small cell lung cancers (NSCLC) and small cell lung cancers (SCLC). NSCLC account for the majority of LC and can be further categories into adenocarcinoma, large cell carcinoma, and squamous cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.